EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing cell-based cancer immunotherapy through stem cell engineering

Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, Miao Li, Pin Wang, Lili Yang

Cell Stem Cell · 2023-05 · 30 (5) · 592-610

DOI: 10.1016/j.stem.2023.02.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Stem Cell, 2023-05. Verfasst von Yan-Ruide Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neoplasms. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, California Institute for Regenerative Medicine, Concern Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenNeoplasmsHumansImmunotherapyImmunotherapy, AdoptiveCell Engineering

Stichwörter der Autor:innen

CRISPR-Cas9T cellT cell receptorallogeneic off-the-shelf cell therapyallorejectioncancer immunotherapychimeric antigen receptorembryonic stem cellfeeder-free culturegamma delta T cellgene engineeringgraft-versus-host diseasehematopoietic stem cellimmune cellinduced pluripotent stem cell

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Mork Family Department of Chemical Engineering and Materials Science, University of Souther…
  • Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA 90089, USA; Department of Pharmacology and Pharmaceutical Sciences, University of Southern Califor…
  • Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of…

Förderung

  • NCI NIH HHS
  • California Institute for Regenerative Medicine
  • Concern Foundation
  • STOP CANCER
  • University of California, Los Angeles
  • National Institutes of Health
  • The Rose Hills Foundation
  • USC

Zitieren

APA

Li, Y. R., Dunn, Z. S., Yu, Y., Li, M., Wang, P., & Yang, L. (2023). Advancing cell-based cancer immunotherapy through stem cell engineering. Cell Stem Cell, 30(5), 592-610. https://doi.org/10.1016/j.stem.2023.02.009

Vancouver

Li YR, Dunn ZS, Yu Y, Li M, Wang P, Yang L. Advancing cell-based cancer immunotherapy through stem cell engineering. Cell Stem Cell. 2023;30(5):592-610. doi:10.1016/j.stem.2023.02.009

BibTeX
@article{Li2023,
  author = {Li, Yan-Ruide and Dunn, Zachary Spencer and Yu, Yanqi and Li, Miao and Wang, Pin and Yang, Lili},
  title = {Advancing cell-based cancer immunotherapy through stem cell engineering},
  journal = {Cell Stem Cell},
  year = {2023},
  volume = {30},
  number = {5},
  pages = {592--610},
  doi = {10.1016/j.stem.2023.02.009}
}
Kostenlos starten →